The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Health Care–Associated Clostridium difficile Infection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality
Open accessAbstract
BACKGROUND: C. difficile infection (CDI) has become an important and frequent nosocomial infection, often resulting in severe morbidity or death. Severe CDI is more frequently seen among individuals infected with the emerging NAP1/027/BI (NAP1) strain and in the elderly population, but the relative importance of these 2 factors remains unclear. We used a large Canadian database of patients with CDI to explore the interaction between these 2 variables. METHODS: The Canada-wide CDI study, performed in 2005 by the Canadian Nosocomial Infection Surveillance Program (CNISP), was used to analyze the role of infecting strain type and patient age on the severity of CDI. A severe outcome was defined as CDI requiring intensive care unit care, colectomy, or causing death (directly or indirectly) within 30 days after diagnosis. RESULTS: A total of 1008 patients in the CNISP database had both complete clinical data and infecting strain analysis documented. A total of 311 patients (31%) were infected with the NAP1 strain, 83 (28%) were infected with the NAP2/J strain, and the rest were infected with various other types. The proportion of NAP1 infections correlated with the incidence and the severity of CDI when analyzed by province. Thirty-nine (12.5%) of the infections due to the NAP1 strain resulted in a severe outcome, compared with only 41 (5.9%) of infections due to the other types (P < .001). The patient's age was strongly associated with a severe outcome, and patients 60-90 years of age were approximately twice as likely to experience a severe outcome if the infection was due to NAP1, compared with infections due to other types. CONCLUSIONS: Our study confirms the strong age association with infection due to the NAP1 strain and severe CDI. In addition, patients 60-90 years of age infected with NAP1 are approximately twice as likely to die or to experience a severe CDI-related outcome, compared with those with non-NAP1 infections. Patients >90 years of age experience high rates of severe CDI, regardless of strain type.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Self-citationWarny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Emergence of Clostridium difficile-associated disease in North America and Europe
Kuijper, E. J., Coignard, B., & Tüll, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01580.x · Cited by 855
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
McDonald, L. C., Owings, M., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.051064 · Cited by 788
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
Recommendations for Surveillance of Clostridium difficile–Associated Disease
McDonald, L. C., Coignard, B., Dubberke, E., Song, X., Horan, T., Kutty, P. K., & the Ad Hoc Clostridium difficile Surveillance Working Group (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/511798 · Cited by 558
Lemee, L., Dhalluin, A., Testelin, S., Mattrat, M.-A., Maillard, K., Lemeland, J.-F., & Pons, J.-L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5710-5714.2004 · Cited by 337
Killgore, G., Thompson, A., Johnson, S., Brazier, J., Kuijper, E., Pepin, J., Frost, E. H., Savelkoul, P., Nicholson, B., van den Berg, R. J., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01484-07 · Cited by 337
Barbut, F., Mastrantonio, P., Delmée, M., Brazier, J., Kuijper, E., & Poxton, I. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01824.x · Cited by 297
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
Kuijper, E. J., Barbut, F., Brazier, J. S., Kleinkauf, N., Eckmanns, T., Lambert, M. L., Drudy, D., Fitzpatrick, F., Wiuff, C., Brown, D. J., et al. (2008) · Eurosurveillance · doi:10.2807/ese.13.31.18942-en · Cited by 287
Gravel, D., Miller, M., Simor, A., Taylor, G., Gardam, M., McGeer, A., Hutchinson, J., Moore, D., Kelly, S., Boyd, D., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596703 · Cited by 243
Self-citationHubert, B., Loo, V. G., Bourgault, A.-M., Poirier, L., Dascal, A., Fortin, E., Dionne, M., & Lorange, M. (2007) · Clinical Infectious Diseases · doi:10.1086/510391 · Cited by 196
Goorhuis, A., Van der Kooi, T., Vaessen, N., Dekker, F. W., Van den Berg, R., Harmanus, C., van den Hof, S., Notermans, D. W., & Kuijper, E. J. (2007) · Clinical Infectious Diseases · doi:10.1086/520984 · Cited by 159
Attributable Outcomes of EndemicClostridium difficile–associated Disease in Nonsurgical Patients
Dubberke, E. R., Butler, A. M., Reske, K. A., Agniel, D. M., Olsen, M. A. A., D’Angelo, G., McDonald, L. C., & Fraser, V. J. (2008) · Emerging infectious diseases · doi:10.3201/eid1407.070867 · Cited by 156
Reller, M. E., Lema, C. A., Perl, T. M., Cai, M., Ross, T. L., Speck, K. A., & Carroll, K. C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01305-07 · Cited by 155
Labbé, A., Poirier, L., MacCannell, D., Louie, T., Savoie, M., Béliveau, C., Laverdière, M., & Pépin, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00146-08 · Cited by 148
Spigaglia, P., & Mastrantonio, P. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45682-0 · Cited by 107
Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study
Morgan, O. W., Rodrigues, B., Elston, T., Verlander, N. Q., Brown, D. F. J., Brazier, J. S., & Reacher, M. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001812 · Cited by 106
Terhes, G., Urbán, E. Z., Sóki, J., Hamid, K. A., & Nagy, E. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.9.4316-4318.2004 · Cited by 91
Clostridium difficile Strain NAP-1 Is Not Associated With Severe Disease in a Nonepidemic Setting
Cloud, J. W., Noddin, L., Pressman, A., Hu, M. Y., & Kelly, C. P. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.018 · Cited by 90
Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure
Clabots, C., Gerding, S. J., Olson, M. M., Peterson, L. R., & Gerding, D. N. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.10.2386-2387.1989 · Cited by 78
Fawley, W. N., Freeman, J., Smith, C., Harmanus, C., van den Berg, R. J., Kuijper, E. J., & Wilcox, M. H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01764-07 · Cited by 60
Cited by
Burden of Clostridium difficile Infection in the United States
Lessa, F. C., Mu, Y., Bamberg, W. M., Beldavs, Z. G., Dumyati, G. K., Dunn, J. R., Farley, M. M., Holzbauer, S. M., Meek, J. I., Phipps, E. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408913 · Cited by 2,641
Debast, S. B., Bauer, M. P., & Kuijper, E. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12418 · Cited by 1,215
Host and Pathogen Factors for Clostridium difficile Infection and Colonization
Loo, V. G., Bourgault, A.-M., Poirier, L., Lamothe, F., Michaud, S., Turgeon, N., Toye, B., Beaudoin, A., Frost, E. H., Gilca, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012413 · Cited by 797
Cornely, O. A., Crook, D. W., Esposito, R., Poirier, A., Somero, M. S., Weiss, K., Sears, P., & Gorbach, S. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70374-7 · Cited by 761
van Prehn, J., Reigadas, E., Vogelzang, E. H., Bouza, E., Hristea, A., Guery, B., Krutova, M., Norén, T., Allerberger, F., Coia, J. E., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.038 · Cited by 640
Metadata
- Authors
- Miller, M., Gravel, D., Mulvey, M., Taylor, G., Boyd, D., Simor, A., Gardam, M., McGeer, A., Hutchinson, J., Moore, D., & Kelly, S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-01-15
- Volume
- 50
- Issue
- 2
- Pages
- 194-201
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2165833212
- Cited by
- 278
- References
- 24
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.